Table 2.
Serum level of T4 in the TBT-treated group compared with the control and the TBT + GTE groups
| T4 (μg/dl) | Control group (n = 15) | TBT treated group (n = 15) | TBT + GTE group (n = 15) | F | p |
|---|---|---|---|---|---|
| Min. – Max. | 4.30–5.50 | 1.20–2.30 | 1.99–2.40 | 385.726* | <0.001* |
| Mean ± SD. | 4.80 ± 0.43 | 1.57 ± 0.38 | 2.16 ± 0.15 | ||
| Median | 4.80 | 1.50 | 2.20 | ||
| Significance between groups | p1 < 0.001*, p2 < 0.001*, p3 < 0.001* | ||||
F: F test (ANOVA), Significance between groups was done using Post Hoc Test (LSD)
p1: p value for comparing between Control and TBT treated groups
p2: p value for comparing between Control and TBT + GTE groups
p3: p value for comparing between TBT treated and TBT + GTE groups
*: Statistically significant at p ≤ 0.05